Boosted the killing potential of CAR‐T cells against HER3‐overexpressing SK‐BR‐3 and BT‐474 breast cancer cell lines (in vitro) and strong antitumour activity in a xenograft model with SK‐BR‐3 tumour cells (in vivo). Here, ERBB3 is linked to neoplasm.